Security key
603380106
MINERVA NEUROSCIENCES, INC. - Common Stock (NERV)
CUSIP: 603380106
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 415
- Total 13F value
- $1,668
- Share change
- +303
- SEC-reported price per share
- $4.02
- Number of holders
- 3
- Value change
- +$1,218
- Number of buys
- 1
- Shares outstanding
- 43,512,717
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
3
Top holders
3
NERV full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Minerva Neurosciences, Inc. SEC filings
Minerva Neurosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 603380106
Recent filing periods:
Ownership snapshot
Top reported holders of NERV - MINERVA NEUROSCIENCES, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Vivo Opportunity Fund Hol...
Disclosed value leader
Vivo Opportunity Fund Hol...
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G
13F
Lead comparable stake: 10%
13D/G row: Vivo Opportunity Fund Holdings, L.P.
Showing 1-6 of 15 holder rows.
Quick read
Vivo Opportunity Fund Holdings, L.P. leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Vivo Opportunity Fund Holdings, L.P.'s linked filing trail.
Comparable ownership
Top 5
Vivo Opportunity Fund Holdings, L.P.
10%
Farallon Capital Partners, L.P.
10%
BALYASNY ASSET MANAGEMENT L.P.
10%
Logos Global Management LP
9.9%
Adage Capital Management, L.P.
6.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. |
13D/G
|
10%
|
$32,476,142
8,591,572 shares
|
$0 | 23 Dec 2025 |
| Farallon Capital Partners, L.P. |
13D/G
Dapice Joshua J.
|
10%
|
$18,250,213
4,539,854 shares
|
$0 | 31 Dec 2025 |
| BALYASNY ASSET MANAGEMENT L.P. |
13D/G
|
10%
|
$17,970,807
4,330,315 shares
|
$0 | 31 Dec 2025 |
| Logos Global Management LP |
13D/G
|
9.9%
|
$18,407,093
4,435,444 shares
|
$0 | 23 Dec 2025 |
| Adage Capital Management, L.P. |
13D/G
|
6.4%
|
$11,777,700
2,838,000 shares
|
$0 | 31 Dec 2025 |
| Boehringer AG |
13D/G
|
3.4%
|
—
1,500,225 shares
|
$0 | 23 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
3
Shares
415
Rows available
3
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
2
Q4 2025 holders
3
Holder diff
1
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend